Pnc Financial Services Group, Inc. Akebia Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$2.22 - $3.78 $4,555 - $7,756	-2,052 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$6.67 - $13.58 $13,686 - $27,866	2,052 New	2,052 $27,000
Q1 2020 May 08, 2020	SELL	$4.1 - $10.24 $450 - $1,126	-110 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$9.15 - $11.34 $2.87 Million - $3.56 Million	-313,786 Reduced 99.96%	110 $0
Q1 2018 May 11, 2018	BUY	$9.53 - $15.68 $2.99 Million - $4.92 Million	313,848 Added 653850.0%	313,896 $0
Q4 2017 Feb 09, 2018	BUY	$14.24 - $19.59 $683 - $940	48	48 $0

121

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $373M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.